文献速递心脑血管急症重症综合管理与镇静镇痛

巨噬细胞特异性蛋白穿孔素-2与心脏骤停后不良神经功能恢复及生存率降低相关

Macrophage-specific protein perforin-2 is associated with poor neurological recovery and reduced survival after sudden cardiac arrest.
PubMed 文献 · Resuscitation · 2020-08-20
一句话结论在成功复苏的院外心脏骤停患者中,复苏后6小时内循环穿孔素-2升高与不良神经功能结局和死亡独立相关,可能辅助预后判断。

该前瞻性多中心研究纳入4个三级医疗中心的144例成功复苏的院外心脏骤停(sR-OHCA)患者,在复苏后6小时内检测循环穿孔素-2及其他常规生物标志物。住院结束时45%患者死亡,46%神经功能结局不良。不良神经功能恢复组血清穿孔素-2水平显著高于良好恢复组(13.7 ± 45.9 vs. 1.2 ± 7.0 ng/mL,p = 0.01),其他常规生物标志物和左心室射血分数无差异。多因素logistic回归显示,穿孔素-2升高(OR 12.78,95%CI 1.0-17.8,p = 0.02)、就诊时昏迷(OR 27.82,95%CI 0.2-19.5,p = 0.02)和不可除颤心律(OR 17.04,95%CI 0.7-15.7,p = 0.01)是不良神经功能结局的显著预测因素。作者认为该数据可指导临床预后判断,并为未来治疗策略提供基础。

要点

  • sR-OHCA患者复苏后6小时内血清穿孔素-2升高与不良神经功能结局独立相关(OR 12.78,95%CI 1.0-17.8,p = 0.02)。
  • 不良神经功能恢复组穿孔素-2水平显著高于良好恢复组(13.7 ± 45.9 vs. 1.2 ± 7.0 ng/mL,p = 0.01)。
  • 就诊时昏迷(OR 27.82,95%CI 0.2-19.5,p = 0.02)和不可除颤心律(OR 17.04,95%CI 0.7-15.7,p = 0.01)也是不良神经功能结局的显著预测因素。
  • 其他常规生物标志物及左心室射血分数在不良与良好神经功能结局组间无差异。
  • 住院结束时45%患者死亡,46%患者神经功能结局不良。

适用人群与场景

  • 成功复苏的院外心脏骤停(sR-OHCA)患者,来自4个三级医疗中心,前瞻性纳入144例。

研究设计与关键结果

  • 研究类型:前瞻性多中心研究,纳入4个三级医疗中心144例sR-OHCA患者,检测复苏后6小时内循环穿孔素-2及其他常规临床生物标志物。
  • 主要结局:住院结束时45%患者死亡,46%患者神经功能结局不良(根据脑功能表现评分二分法)。
  • 不良神经功能恢复组血清穿孔素-2水平显著高于良好恢复组(13.7 ± 45.9 vs. 1.2 ± 7.0 ng/mL,p = 0.01)。
  • 其他常规生物标志物和左心室射血分数在组间无差异。
  • 多因素logistic回归显示,穿孔素-2升高(OR 12.78,95%CI 1.0-17.8,p = 0.02)、就诊时昏迷(OR 27.82,95%CI 0.2-19.5,p = 0.02)和不可除颤心律(OR 17.04,95%CI 0.7-15.7,p = 0.01)是不良神经功能结局的显著预测因素。

证据类型、等级与局限

  • 证据类型:前瞻性多中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些数据可指导临床医生对sR-OHCA患者的生存和神经功能结局进行预后判断,并为进一步的治疗方法提供基础。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Biomarkers involved in inflammation and stress response were implicated in patients who were successfully resuscitated from out of hospital cardiac arrest (sR-OHCA). Here we report that macrophage-expressed gene, perforin-2, an evolutionarily conserved protein with membrane attack domain, is associated with poor neurological outcomes and mortality after sR-OHCA.

OBJECTIVES: To examine the association between circulating perforin-2 protein measured within 6-h of sR-OHCA, mortality and neurological outcomes.

METHODS: We prospectively enrolled 144 sR-OHCA patients from 4 different tertiary care centers. We measured perforin-2 and other conventional clinical biomarkers and compared between survivors vs. non-survivors. The neurological outcomes were dichotomized as poor or good according to the cereberal performance score.

RESULTS: At the end of the hospital stay, 45% of the patients had died and 46% had poor neurological outcomes. Serum perforin-2 levels were significantly higher in patients with poor neurological recovery, compared to the ones with good neurological recovery (ng/mL, 13.7 ± 45.9 vs. 1.2 ± 7.0, p = 0.01). There were no differences in other routinely measured biomarkers and left ventricular ejection fraction. On multivariate logistic regression, elevated perforin-2 (OR: 12.78, 95% CI: 1.0-17.8, p = 0.02), comatose on presentation (OR: 27.82, 95% CI: 0.2-19.5, p = 0.02) and non-shockable rhythm (OR: 17.04, 95% CI: 0.7-15.7, p = 0.01) were the significant predictors of poor neurological outcome.

CONCLUSIONS: This study reports a novel macrophage-expressed circulating biomarker perforin-2 to be strongly associated with reduced survival and poor neurological outcomes in sR-OHCA. These data can guide clinicians to prognosticate survival and neurological outcomes in sR-OHCA, and also form the basis for future therapeutic approaches.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Kattel S, Bhatt H, Xu S, et al. Macrophage-specific protein perforin-2 is associated with poor neurological recovery and reduced survival after sudden cardiac arrest. Resuscitation. 2020. PMID: 32828820. doi:10.1016/j.resuscitation.2020.08.005

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。